Search Results

There are 1239 results for: content related to: Guidelines for the Management of Hepatitis C Virus Infection

  1. Validation of a sensitive LC/MS/MS method for the determination of telaprevir and its R-isomer in human plasma

    Biomedical Chromatography

    Volume 28, Issue 12, December 2014, Pages: 1714–1721, Xinhui Chen, Lane R. Bushman, Kevin J. McAllister, Peter L. Anderson and Jennifer J. Kiser

    Version of Record online : 24 APR 2014, DOI: 10.1002/bmc.3211

  2. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  3. You have free access to this content
    The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 75, Issue 2, February 2013, Pages: 431–439, Varun Garg, Gurudatt Chandorkar, Yijun Yang, Nathalie Adda, Lindsay McNair, Katia Alves, Frances Smith and Rolf P. G. van Heeswijk

    Version of Record online : 10 JAN 2013, DOI: 10.1111/j.1365-2125.2012.04345.x

  4. You have free access to this content
    Optimal treatment with telaprevir for chronic HCV infection

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 3–13, Arun B. Jesudian and Ira M. Jacobson

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12079

  5. Cocrystalline Solids of Telaprevir with Enhanced Oral Absorption

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 10, October 2015, Pages: 3343–3350, Kathy Stavropoulos, Steven C. Johnston, Yuegang Zhang, Bhisetti Govinda Rao, Michael Hurrey, Patricia Hurter, Elizabeth M. Topp and Irina Kadiyala

    Version of Record online : 11 JUN 2015, DOI: 10.1002/jps.24534

  6. Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two-way crossover trial

    The Journal of Clinical Pharmacology

    Volume 54, Issue 5, May 2014, Pages: 563–573, Thomas N. Kakuda, Lorant Leopold, Steven Nijs, Ann Vandevoorde, Herta M. Crauwels, Kirk M. Bertelsen, Marita Stevens, James Witek, Yvon van Delft, Frank Tomaka and Richard M.W. Hoetelmans

    Version of Record online : 3 APR 2014, DOI: 10.1002/jcph.245

  7. You have free access to this content
    Telaprevir user's guide

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 17–25, Ann Marie Liapakis and Ira Jacobson

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02708.x

  8. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  9. You have free access to this content
    Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C

    Hepatology

    Volume 46, Issue 3, September 2007, Pages: 640–648, Nicole Forestier, Hendrik W. Reesink, Christine J. Weegink, Lindsay McNair, Tara L. Kieffer, Hui-May Chu, Susan Purdy, Peter L.M. Jansen and Stefan Zeuzem

    Version of Record online : 24 AUG 2007, DOI: 10.1002/hep.21774

  10. You have free access to this content
    Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients

    Hepatology Research

    Volume 44, Issue 10, October 2014, Pages: E163–E171, Hitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka, Norio Akuta, Taito Fukushima, Tasuku Hara, Yusuke Kawamura, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 8 JAN 2014, DOI: 10.1111/hepr.12268

  11. You have free access to this content
    Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus

    Hepatology

    Volume 54, Issue 1, July 2011, Pages: 20–27, Varun Garg, Rolf van Heeswijk, Jee Eun Lee, Katia Alves, Priya Nadkarni and Xia Luo

    Version of Record online : 24 JUN 2011, DOI: 10.1002/hep.24443

  12. Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypes

    Journal of Viral Hepatitis

    Volume 20, Issue 6, June 2013, Pages: 395–403, S. De Meyer, A. Ghys, G. R. Foster, M. Beumont, B. Van Baelen, T.-I. Lin, I. Dierynck, H. Ceulemans and G. Picchio

    Version of Record online : 10 JAN 2013, DOI: 10.1111/jvh.12046

  13. You have free access to this content
    Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 1, January 2014, Pages: 93–103, L. I. Backus, P. S. Belperio, T. A. Shahoumian, R. Cheung and L. A. Mole

    Version of Record online : 10 NOV 2013, DOI: 10.1111/apt.12546

  14. You have free access to this content
    Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV

    IUBMB Life

    Volume 65, Issue 9, September 2013, Pages: 800–805, Massimo Tempestilli, Elisa Milano, Gianpiero D'Offizi, Marzia Montalbano, Antonio D'Avolio, Tecla Gasperi, Pasquale Narciso, Paolo Ascenzi and Leopoldo P. Pucillo

    Version of Record online : 29 JUL 2013, DOI: 10.1002/iub.1197

  15. Effect of Telaprevir on the Pharmacokinetics of Midazolam and Digoxin

    The Journal of Clinical Pharmacology

    Volume 52, Issue 10, October 2012, Pages: 1566–1573, Dr Varun Garg, Dr Gurudatt Chandorkar, Dr H. Frank Farmer, Dr Frances Smith, Dr Katia Alves and Dr Rolf P. G. van Heeswijk

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011419850

  16. Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1

    Liver International

    Volume 34, Issue 6, July 2014, Pages: 869–889, Dominique Salmon-Ceron, Cédric Arvieux, Marc Bourlière, Patrice Cacoub, Philippe Halfon, Karine Lacombe, Georges-Philippe Pageaux, Gilles Pialoux, Lionel Piroth, Isabelle Poizot-Martin, Eric Rosenthal and Stanislas Pol

    Version of Record online : 25 NOV 2013, DOI: 10.1111/liv.12363

  17. You have free access to this content
    Review article: specifically targeted anti-viral therapy for hepatitis C – a new era in therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 1, July 2010, Pages: 14–28, C. M. Lange, C. Sarrazin and S. Zeuzem

    Version of Record online : 31 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04317.x

  18. You have free access to this content
    Telaprevir and pegylated interferon–alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients

    Hepatology

    Volume 46, Issue 3, September 2007, Pages: 631–639, Tara L. Kieffer, Christoph Sarrazin, Janice S. Miller, Martin W. Welker, Nicole Forestier, Hendrik W. Reesink, Ann D. Kwong and Stefan Zeuzem

    Version of Record online : 6 AUG 2007, DOI: 10.1002/hep.21781

  19. Effect of telaprevir on the metabolism and hepatic uptake of tacrolimus (FK506)

    Biopharmaceutics & Drug Disposition

    Volume 35, Issue 9, December 2014, Pages: 501–512, Kazuo Oda and Katsuhiro Yamano

    Version of Record online : 1 SEP 2014, DOI: 10.1002/bdd.1913

  20. The Pharmacokinetic Interaction Between an Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone and the HCV Protease Inhibitor Telaprevir

    The Journal of Clinical Pharmacology

    Volume 52, Issue 10, October 2012, Pages: 1574–1583, Dr Varun Garg, Dr Rolf van Heeswijk, Dr Yijun Yang, Dr Robert Kauffman, Dr Frances Smith and Dr Nathalie Adda

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011419855